Related Experiment Videos
[Clinical experience with fluconazole monotherapy in cryptococcal meningitis: report of four cases]
1Department of Neurology, National Cheng Kung University Medical Center, Tainan, Taiwan.
Abstract:
Four patients with cryptococcal meningitis have been treated with fluconazole in the past two years at the Department of Neurology, National Cheng Kung University Medical Center. There were three women and one man. Two patients had a history of anemia and one had undergone a splenectomy due to hypersplenism. Two patients were healthy before the onset of meningitis. After receiving fluconazole 300 mg per day for 8 to 13 weeks, three patients were cured without clinical evidence of recurrence during follow-up lasting from 2 to 17 months. One patient died from pneumothorax as a complication of subclavian vein cannulation. During the treatment course, there was no side effect except for one patient who had transient elevation of the GOT and GPT values which reversed spontaneously without a change in dosage. In the three successfully treated cases, the cryptococcal antigen titers began to decrease after the first week of treatment. Our preliminary experience shows that fluconazole alone is an effective and safe drug for the treatment of cryptococcal meningitis.
Insights
Fluconazole effectively treated cryptococcal meningitis in three of four patients, showing rapid antigen titer reduction. This preliminary study suggests fluconazole is a safe and effective monotherapy for this serious fungal infection.
Area of Science:
- Neurology
- Infectious Diseases
- Mycology
Background:
- Cryptococcal meningitis is a serious fungal infection, particularly in immunocompromised individuals.
- Antifungal treatment options for cryptococcal meningitis require careful consideration of efficacy and safety.
Observation:
- Four patients with cryptococcal meningitis received fluconazole 300 mg daily for 8-13 weeks.
- Three patients achieved clinical cure with no recurrence during follow-up (2-17 months).
- One patient died due to a complication unrelated to the antifungal treatment.
Findings:
- Fluconazole demonstrated significant efficacy, with decreasing cryptococcal antigen titers observed within the first week of treatment in successfully treated cases.
- The treatment was well-tolerated, with only one patient experiencing transient, self-resolving elevation of liver enzymes (GOT and GPT).
Implications:
- Fluconazole monotherapy appears to be a safe and effective treatment option for cryptococcal meningitis.
- Further research with larger cohorts is warranted to confirm these preliminary findings and establish optimal treatment protocols.